Source: International Congress 2018 – New tools for managing respiratory failure
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Park (Seongnam-si, Republic of Korea), Y. Kim (Seongnam-si, Republic of Korea), J. Park (Seongnam-si, Republic of Korea), E. Kim (Seongnam-si, Republic of Korea), S. Lee (Seongnam-si, Republic of Korea), Y. Lee (Seongnam-si, Republic of Korea), J. Park (Seongnam-si, Republic of Korea), H. Yoon (Seongnam-si, Republic of Korea), J. Lee (Seongnam-si, Republic of Korea), C. Lee (Seongnam-si, Republic of Korea), Y. Cho (Seongnam-si, Republic of Korea). High Flow nasal OXygen therapy in high risk patients of hypoxia undergoing diagnostic BRONCHOscopy (HiFOXy-BRONCHO):a prospective, randomized, controlled study. 2405

Member's Comments

No comment yet.

Related content which might interest you: Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006 High flow nasal cannula during walking in severe COPD patients: a randomized controlled trial. Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018 Positive effect of MusiCure on patients undergoing bronchochoscopy - A randomized controlled trial Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Evidence generation for the clinical impact of myCOPD in patients with mild, moderate and newly diagnosed COPD: a randomised controlled trial Source: ERJ Open Res, 6 (4) 00460-2020; 10.1183/23120541.00460-2020 Year: 2020 Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX) Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment Year: 2018 Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 The evaluation of the efficacy and safety of phospholipids‘ inhalation in patients with bronchial asthma (BA): A prospective randomized placebo-controlled study Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Sequential screening for lung cancer in a high-risk group: randomised controlled trial Source: Eur Respir J, 54 (4) 1900581; 10.1183/13993003.00581-2019 Year: 2019 Augmentation therapy for α1-antitrypsin deficiency: a meta-analysis of randomized and non-randomized clinical studies Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005 Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 A double-blind randomised controlled trial of protein supplementation to enhance exercise capacity in COPD during pulmonary rehabilitation: a pilot study Source: ERJ Open Res, 7 (1) 00077-2021; 10.1183/23120541.00077-2021 Year: 2021 Survival rates among COVID-19 patients treated with high flow nasal oxygen therapy with a do-not-intubate-order: an observational study Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond Year: 2021 Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT) Source: International Congress 2017 – Many faces of asthma assessment Year: 2017 Self-proning in COVID-19 patients on low-flow oxygen therapy. A cluster randomised controlled trial Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 Home care combining oral nutritional supplement, exercise and androgen substitution in malnourished patients with chronic respiratory failure: a prospective controlled randomized multicenter trial Source: Annual Congress 2008 - Integrated care and long-term strategies Year: 2008 Evaluation of ICS/LABA combination therapy on respiratory function in patients with asthma: Open-label, randomized, cross-over trial. Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Self-proning in COVID-19 patients on low-flow oxygen therapy: a cluster randomised controlled trial Source: ERJ Open Res, 7 (1) 00692-2020; 10.1183/23120541.00692-2020 Year: 2021 Analysis of the efficacy of moxifloxacin for the treatment of bronchial colonization in COPD patients using microbial molecular typing: a randomized, double-blind, placebo-controlled study Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008